Table 1. Comparison of baseline characteristics between high- and low-NLR groups in luminal A breast cancer.
| Characteristics | High NLR (n=121), No. (%) | Low NLR (n=105), No. (%) | P value |
|---|---|---|---|
| Age at diagnosis | 0.876 | ||
| ≤50 years | 76 (62.8) | 67 (63.8) | |
| >50 years | 45 (37.2) | 38 (36.2) | |
| T stage | 0.386 | ||
| T1 | 44 (36.4) | 46 (43.8) | |
| T2 | 60 (49.6) | 49 (46.7) | |
| T3 | 4 (3.3) | 5 (4.8) | |
| T4 | 12 (9.9) | 5 (4.8) | |
| Unknown | 1 (0.8) | 0 (0.0) | |
| N stage | 0.267 | ||
| N0 | 76 (62.8) | 63 (60.0) | |
| N1 | 17 (14.0) | 25 (23.8) | |
| N2 | 16 (13.3) | 11 (10.5) | |
| N3 | 11 (9.1) | 6 (5.7) | |
| Unknown | 1 (0.8) | 0 (0.0) | |
| Neoadjuvant | 0.815 | ||
| Yes | 21 (17.4) | 17 (16.2) | |
| No | 100 (82.6) | 88 (83.8) | |
| Vascular tumor thrombus | 0.232 | ||
| Yes | 19 (15.7) | 23 (21.9) | |
| No | 102 (84.3) | 82 (78.1) | |
| G-CSF | 0.407 | ||
| Yes | 17 (14.0) | 19 (18.1) | |
| No | 104 (86.0) | 86 (81.9) | |
| Histology grade | 0.407 | ||
| I | 16 (13.2) | 10 (9.5) | |
| II | 75 (62.0) | 65 (61.9) | |
| III | 3 (2.5) | 7 (6.7) | |
| Unknown | 27 (22.3) | 23 (21.9) | |
| PR status | 0.163 | ||
| 20–39 | 15 (12.4) | 7 (6.7) | |
| 40–59 | 6 (5.0) | 11 (10.5) | |
| 60–79 | 23 (19.0) | 15 (14.3) | |
| ≥80 | 77 (63.6) | 72 (68.6) | |
| ER status | 0.695 | ||
| ≤20 | 6 (5.0) | 6 (5.7) | |
| 21–40 | 3 (2.5) | 4 (3.8) | |
| 41–60 | 12 (9.9) | 6 (5.7) | |
| 61–80 | 47 (38.8) | 37 (35.2) | |
| ≥81 | 53 (43.8) | 52 (49.5) | |
NLR, neutrophil-tolymphocyte ratio; G-CSF, granulocyte colony stimulating factor; PR, progesterone receptor; ER, estrogen receptor.